Seminars in Diagnostic Pathology
Volume 20, Issue 2 , Pages 105-120 , May 2003

Splenic involvement by peripheral T-cell and NK-cell neoplasms

  • John K.C Chan, MD

      Affiliations

    • Department of Pathology, Queen Elizabeth Hospital, Hong Kong, S.A.R. China
    • Corresponding Author InformationAddress reprint requests to John K.C. Chan, MD, Department of Pathology, Queen Elizabeth Hospital, Wylie Road, Kowloon, Hong Kong, S.A.R. China

References 

  1. Neiman RS, Orazi A. Disorders of the Spleen. In: ed 2. Major Problems in Pathology. vol 38:Philadelphia, PA: Saunders; 1999;
  2. Wilkins BS, Wright DH. Illustrated Pathology of the Spleen. Cambridge: Cambridge University Press; 2000;
  3. Neiman RS, Orazi A. Hematolymphoid disorders involving spleen. In:  Knowles DM editors. Neoplastic Hematopathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001;
  4. Arber DA, Rappaport H, Weiss LM. Non-Hodgkin’s lymphoproliferative disorders involving the spleen. Mod Pathol. 1997;10:18–32
  5. Arber DA, Rappaport H, Weiss LM. Non-Hodgkin’s lymphoproliferative disorders involving the spleen. Mod Pathol. 1997;10:18–32
  6. Kraus MD, Fleming MD, Vonderheide RH. The spleen as a diagnostic specimen (A review of 10 years’ experience at two tertiary care institutions). Cancer. 2001;91:2001–2009
  7. Stroup RM, Burke JS, Sheibani K, et al.  Splenic involvement by aggressive malignant lymphomas of B-cell and T- cell types (A morphologic and immunophenotypic study). Cancer. 1992;69:413–420
  8. Falk S, Stutte HJ. Primary malignant lymphomas of the spleen (A morphologic and immunohistochemical analysis of 17 cases). Cancer. 1990;66:2612–2619
  9. Warnke RA, Weiss LM, Chan JK, et al.  Tumors of the Lymph Nodes and Spleen. In: Atlas of Tumor Pathology. Washington D.C: Armed Forces Institute of Pathology; 1995; 3rd series,Fascicle 14
  10. Falk S, Karhoff M, Takeshita M, et al.  Primary pleomorphic T-cell lymphoma of the spleen. Histopathology. 1990;16:191–192
  11. Cuevas E, Ortiz-Hidalgo C, Oliva H, et al.  Primary pleomorphic T-cell lymphoma of the spleen. Leuk Lymphoma. 1993;9:265–267
  12. Sakadamis A, Ballas K, Denga K, et al.  Primary anaplastic large cell lymphoma of the spleen presenting as a splenic abscess. Leuk Lymphoma. 2001;42:1419–1421
  13. Jaffe ES, Ralfkiaer E. Hepatosplenic T-cell lymphoma. In:  Jaffe ES,  Harris NL,  Stein H, et al. editor. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 210–211
  14. Jaffe ES. Hepatosplenic gamma delta T cell lymphoma. In:  Mason DY,  Harris NL editor. Human Lymphoma (Clinical Implications of the REAL Classification). London: Springer-Verlag; 1999;p. 35.1–35.4
  15. Kumar S, Lawlor C, Jaffe ES. Hepatosplenic T-cell lymphoma of alphabeta lineage. Am J Surg Pathol. 2001;25:970–971
  16. Lai R, Larratt LM, Etches W, et al.  Hepatosplenic T-cell lymphoma of alpha-beta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia. Am J Surg Pathol. 2000;24:459–463
  17. Macon WR, Levy NB, Kurtin PJ, et al.  Hepatosplenic alphabeta T-cell lymphomas (A report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas). Am J Surg Pathol. 2001;25:285–296
  18. Suarez F, Wlodarska I, Rigal-Huguet F, et al.  Hepatosplenic alphabeta T-cell lymphoma (an unusual case in the clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma). Am J Surg Pathol. 2000;24:1027–1032
  19. Ross CW, Schnitzer B, Sheldon S, et al.  Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol. 1994;102:310–315
  20. Salhany KE, Feldman M, Peritt D, et al.  Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders. [letter; comment] Blood. 1997;89:3490–3491
  21. Kraus MD, Crawford DF, Kaleem Z, et al.  T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder (A case report). Cancer. 1998;82:983–992
  22. Francois A, Lesesve JF, Stamatoullas A, et al.  Hepatosplenic gamma/delta T-cell lymphoma (A report of two cases in immunocompromised patients, associated with isochromosome 7q). Am J Surg Pathol. 1997;21:781–790
  23. Khan WA, Yu L, Eisenbrey AB, et al.  Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients (Report of two cases and review of literature). Am J Clin Pathol. 2001;116:41–50
  24. Roncella S, Cutrona G, Truini M, et al.  Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient. Haematologica. 2000;85:256–262
  25. Wu H, Wasik MA, Przybylski G, et al.  Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol. 2000;113:487–496
  26. Ozaki S, Ogasahara K, Kosaka M, et al.  Hepatosplenic gamma delta T-cell lymphoma associated with hepatitis B virus infection. J Med Invest. 1998;44:215–217
  27. Yao M, Tien HF, Lin MT, et al.  Clinical and hematological characteristics of hepatosplenic T gamma/delta lymphoma with isochromosome for long arm of chromosome 7. Leuk Lymphoma. 1996;22:495–500
  28. Farcet JP, Gaulard P, Marolleau JP, et al.  Hepatosplenic T-cell lymphoma (Sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta). Blood. 1990;75:2213–2219
  29. Wong KF, Chan JK, Matutes E, et al.  Hepatosplenic gamma delta T-cell lymphoma (A distinctive aggressive lymphoma type). [see comments] Am J Surg Pathol. 1995;19:718–726
  30. Cooke CB, Krenacs L, Stetler-Stevenson M, et al.  Hepatosplenic T-cell lymphoma (A distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin). Blood. 1996;88:4265–4274 [see comments]
  31. Chang KL, Arber DA. Hepatosplenic gamma delta T-cell lymphoma-not just alphabet soup. Adv Anat Pathol. 1998;5:21–29
  32. Ooi J, Iseki T, Adachi D, et al.  Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma. Haematologica. 2001;86:E25
  33. Grigg AP. 2′-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma. Leuk Lymphoma. 2001;42:797–799
  34. Iannitto E, Barbera V, Quintini G, et al.  Hepatosplenic gammadelta T-cell lymphoma (Complete response induced by treatment with pentostatin). Br J Haematol. 2002;117:995–996
  35. Sallah S, Smith SV, Lony LC, et al.  Gamma/delta T-cell hepatosplenic lymphoma (review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia). Ann Hematol. 1997;74:139–142
  36. Salhany KE, Feldman M, Kahn MJ, et al.  Hepatosplenic gammadelta T-cell lymphoma (Ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation). Hum Pathol. 1997;28:674–685
  37. Vega F, Medeiros LJ, Bueso-Ramos C, et al.  Hepatosplenic gamma/delta T-cell lymphoma in bone marrow (A sinusoidal neoplasm with blastic cytologic features). Am J Clin Pathol. 2001;116:410–419
  38. Coventry S, Punnett HH, Tomczak EZ, et al.  Consistency of isochromosome 7q and trisomy 8 in hepatosplenic gammadelta T-cell lymphoma (Detection by fluorescence In situ hybridization of a splenic touch-preparation from a pediatric patient). Pediatr Dev Pathol. 1999;2:478–483
  39. Wang CC, Tien HF, Lin MT, et al.  Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma (a new cytogenetic-clinicopathologic entity). Genes Chromosomes Cancer. 1995;12:161–164
  40. Jonveaux P, Daniel MT, Martel V, et al.  Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma. Leukemia. 1996;10:1453–1455
  41. Alonsozana EL, Stamberg J, Kumar D, et al.  Isochromosome 7q (The primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma). Leukemia. 1997;11:1367–1372 [letter]
  42. Wlodarska I, Martin-Garcia N, Achten R, et al.  Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma (isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression). Genes Chromo Cancer. 2002;33:243–251
  43. Ohshima K, Haraoka S, Harada N, et al.  Hepatosplenic gammadelta T-cell lymphoma (Relation to Epstein-Barr virus and activated cytotoxic molecules). Histopathology. 2000;36:127–135
  44. Catovsky D, Matutes E. Leukemias of mature T cells. In:  Knowles DM editors. Neoplastic Hematopathology. 2nd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2001;p. 1589–1602
  45. Lamy T, Loughran TP. Large granular lymphocyte leukemia. Cancer Control. 1998;5:25–33
  46. Lamy T, Loughran TP. Current concepts (large granular lymphocyte leukemia). Blood Rev. 1999;13:230–240
  47. Loughran TP. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1–14
  48. Agnarsson BA, Loughran TP, Starkebaum G, et al.  The pathology of large granular lymphocyte leukemia. Hum Pathol. 1989;20:643–651
  49. Hanson CA, Bockenstedt PL, Schnitzer B, et al.  S100-positive, T-cell chronic lymphoproliferative disease (An aggressive disorder of an uncommon T-cell subset). Blood. 1991;78:1803–1813
  50. Chan JK, Ng CS, Chu YC, et al.  S-100 protein-positive sinusoidal large cell lymphoma. Hum Pathol. 1987;18:756–759
  51. Ruco LP, Stoppacciaro A, Barsotti P, et al.  S-100+ lymph node neoplasm. Report of a case with histological AL and immunological features intermediate between T cell lymphoma and malignant histiocytosis. Virchows Arch A Pathol Anat Histopathol. 1984;404:351–358
  52. Takahashi K, Ohtsuki Y, Sonobe H, et al.  S-100 beta positive T cell leukemia. Blood. 1988;71:1299–1303
  53. Zarate-Osorno A, Raffeld M, Berman EL, et al.  S-100-positive T-cell lymphoproliferative disorder (A case report and review of the literature). Am J Clin Pathol. 1994;102:478–482
  54. Braun DK, Pellett PE, Hanson CA. Presence and expression of human herpesvirus 6 in peripheral blood mononuclear cells of S100-positive, T cell chronic lymphoproliferative disease. J Infect Dis. 1995;171:1351–1355
  55. McKenna RW, Risdall RJ, Brunning RD. Virus associated hemophagocytic syndrome. Hum Pathol. 1981;12:395–398
  56. Risdall RJ. Pathologic anatomy (virus-associated hemophagocytic syndrome). Minn Med. 1980;63:879–880
  57. Risdall RJ, McKenna RW, Nesbit ME, et al.  Virus-associated hemophagocytic syndrome (A benign histiocytic proliferation distinct from malignant histiocytosis). Cancer. 1979;44:993–1002
  58. Wong KF, Chan JK. Reactive hemophagocytic syndrome (A clinicopathologic study of 40 patients in an Oriental population). Am J Med. 1992;93:177–180
  59. Chan JK, Ng CS, Law CK, et al.  Reactive hemophagocytic syndrome (A study of 7 fatal cases). Pathology. 1987;19:43–50
  60. Wong KF, Chan JKC. Hemophagocytic disorders (A review). Hematol Rev. 1991;5:5–37
  61. Wong KF, Chan JK, Lo ES, et al.  A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Hum Pathol. 1996;27:1239–1242
  62. Takahashi N, Miura I, Chubachi A, et al.  A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol. 2001;74:303–308
  63. Su IJ, Hsu YH, Lin MT, et al.  Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer. 1993;72:2019–2027
  64. Chan EY, Pi D, Chan GT, et al.  Peripheral T-cell lymphoma presenting as hemophagocytic syndrome. Hematol Oncol. 1989;7:275–285
  65. Falini B, Pileri S, De Solas I, et al.  Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood. 1990;75:434–444 [see comments]
  66. Braylan RC, Long JC, Jaffe ES, et al.  Malignant lymphoma obscured by concomitant extensive epithelioid granulomas (Report of three cases with similar clinicopathologic features). Cancer. 1977;39:1146–1155
  67. Narang S, Wolf BC, Neiman RS. Malignant lymphoma presenting with prominent splenomegaly (A clinicopathologic study with special reference to intermediate cell lymphoma). Cancer. 1985;55:1948–1957
  68. Brox A, Bishinsky JI, Berry G. Primary non-Hodgkin lymphoma of the spleen. Am J Hematol. 1991;38:95–100
  69. Chan JKC, Wong KF, Jaffe ES, Ralfkiaer E. Aggressive NK-cell leukemia. In:  Jaffe ES,  Harris NL,  Stein H, et al. editor. Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 198–200
  70. Chan JK. Natural killer cell neoplasms. Anat Pathol. 1998;3:77–145
  71. Chan JK. Peripheral T-cell and NK-cell neoplasms (An integrated approach to diagnosis). Mod Pathol. 1999;12:177–199
  72. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In:  Jaffe ES,  Harris NL,  Stein H, et al. editor. Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;p. 204–207
  73. Chan JK, Sin VC, Wong KF, et al.  Nonnasal lymphoma expressing the natural killer cell marker CD56 (A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm). Blood. 1997;89:4501–4513

PII: S0740-2570(03)00013-3

doi: 10.1016/S0740-2570(03)00013-3

Seminars in Diagnostic Pathology
Volume 20, Issue 2 , Pages 105-120 , May 2003

Article Tools

* Image Usage & Resolution